Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

EXAS

Exact Sciences Corp

Mar 14 • 04:00PM ET

45.00

Dollar change +1.96
Percentage change 4.55	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN GH NTRA TXG DGX FLGT BIO QDEL MYGN CSTM

| Held by: VTI VB VXF VBK XBI VHT FBT IWR SCHM IWP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.56	Insider Own	1.48%	Shs Outstand	185.62M	Perf Week	-4.38%
Market Cap	8.36B	Forward P/E	68.07	EPS next Y	0.66	Insider Trans	0.65%	Shs Float	183.01M	Perf Month	-10.61%
Income	-1028.86M	PEG	-	EPS next Q	-0.33	Inst Own	99.54%	Short Float	5.83%	Perf Quarter	-26.92%
Sales	2.76B	P/S	3.03	EPS this Y	94.58%	Inst Trans	-1.12%	Short Ratio	4.84	Perf Half Y	-29.82%
Book/sh	12.94	P/B	3.48	EPS next Y	318.32%	ROA	-15.72%	Short Interest	10.66M	Perf Year	-25.86%
Cash/sh	5.59	P/C	8.05	EPS next 5Y	-	ROE	-37.09%	52W Range	40.62 - 79.62	Perf YTD	-19.91%
Dividend Est.	-	P/FCF	112.13	EPS past 5Y	-54.24%	ROI	-21.02%	52W High	-43.48%	Beta	1.13
Dividend TTM	-	Quick Ratio	1.92	Sales past 5Y	27.39%	Gross Margin	69.27%	52W Low	10.77%	ATR (14)	2.43
Dividend Ex-Date	-	Current Ratio	2.15	EPS Y/Y TTM	-389.98%	Oper. Margin	-7.26%	RSI (14)	37.74	Volatility	5.19% 5.17%
Employees	7000	Debt/Eq	1.16	Sales Y/Y TTM	10.37%	Profit Margin	-37.29%	Recom	1.43	Target Price	70.18
Option/Short	Yes / Yes	LT Debt/Eq	1.04	EPS Q/Q	-1597.82%	Payout	-	Rel Volume	0.77	Prev Close	43.04
Sales Surprise	1.60%	EPS Surprise	-1421.17%	Sales Q/Q	10.29%	Earnings	Feb 19 AMC	Avg Volume	2.20M	Price	45.00
SMA20	-5.89%	SMA50	-13.44%	SMA200	-19.21%	Trades		Volume	1,704,010	Change	4.55%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-13-25	Initiated	RBC Capital Mkts	Sector Perform	$52
Jan-23-25	Initiated	Barclays	Overweight	$70
Aug-28-24	Initiated	Wells Fargo	Overweight	$75
Jun-27-24	Initiated	Scotiabank	Sector Outperform	$70
Jun-03-24	Resumed	Jefferies	Buy	$75
Jan-02-24	Upgrade	The Benchmark Company	Hold → Buy	$91
Dec-14-23	Initiated	Guggenheim	Buy	$90
Dec-13-23	Initiated	Wolfe Research	Outperform	$95
Oct-10-23	Upgrade	Piper Sandler	Neutral → Overweight	$90
Sep-28-23	Initiated	Bernstein	Outperform	$83
Aug-02-23	Downgrade	The Benchmark Company	Buy → Hold
May-10-23	Upgrade	Craig Hallum	Hold → Buy	$55 → $85
May-05-23	Initiated	UBS	Neutral	$73
Mar-09-23	Upgrade	Citigroup	Neutral → Buy	$70 → $90
Feb-10-23	Downgrade	Credit Suisse	Outperform → Neutral	$50 → $70
Jan-18-23	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-19-22	Downgrade	Craig Hallum	Buy → Hold	$60 → $35
Aug-25-22	Initiated	Credit Suisse	Outperform	$55
Jun-03-22	Initiated	Piper Sandler	Neutral	$50
Nov-03-21	Downgrade	Raymond James	Strong Buy → Outperform	$160 → $130

Show Previous Ratings

Mar-14-25 09:01AM	1 Stock Under $50 to Target This Week and 2 to Turn Down (StockStory)
Mar-12-25 09:00AM	Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner (Business Wire)
Mar-04-25 09:00AM	Heres What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS) (Insider Monkey)
Mar-03-25 06:48PM	Exact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy Now (Insider Monkey)
Feb-24-25 12:00PM	2 Stocks Down 59% and 34% to Buy and Hold (Motley Fool)
06:00AM	Loading…
06:00AM	Exact Sciences to Participate in March Investor Conferences (Business Wire)
Feb-20-25 07:01PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
01:40PM	Why Exact Sciences (EXAS) Shares Are Trading Lower Today (StockStory)
08:25AM	Q4 2024 Exact Sciences Corp Earnings Call (Thomson Reuters StreetEvents)
02:12AM	Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
12:30AM	Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript (Motley Fool)
Feb-19-25 05:25PM	Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:42PM	Exact Sciences: Q4 Earnings Snapshot (Associated Press Finance)
04:22PM	Exact Sciencess (NASDAQ:EXAS) Q4: Beats On Revenue (StockStory)
04:05PM	Exact Sciences Announces Fourth Quarter 2024 Results (Business Wire)
08:03AM	Loading…
Feb-18-25 08:03AM	Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-12-25 05:57PM	Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts (Yahoo Finance)
10:00AM	Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Feb-06-25 08:30AM	Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members (GlobeNewswire)
Feb-03-25 06:00AM	Exact Sciences Schedules Fourth Quarter 2024 Earnings Call (Business Wire)
Jan-22-25 07:39AM	Exact Sciences post positive results from MRD trial (Clinical Trials Arena)
Jan-21-25 05:05PM	New Evidence Validates Oncodetect's Ability to Detect Molecular Residual Disease and Predict Recurrence in Colorectal Cancer Patients (Business Wire)
05:05PM	Exact Sciences Demonstrates Leadership in Cancer Innovation with New Data on Screening and Molecular Residual Disease at 2025 ASCO GI Symposium (Business Wire)
04:03PM	Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone (Investor's Business Daily)
Jan-17-25 06:15AM	Why Exact Sciences (EXAS) Is Crashing? (Insider Monkey)
Jan-16-25 09:15PM	Analyst Report: Exact Sciences Corporation (Morningstar Research) -5.75%
04:05PM	Exact Sciences Stock Drops 11% Over Four Days. 'What Is Going On?' (Investor's Business Daily)
05:22AM	2 Healthcare Stocks to Buy Hand Over Fist in January (Motley Fool)
Jan-12-25 07:00PM	Exact Sciences Announces Preliminary Fourth Quarter 2024 Results (Business Wire)
Jan-03-25 06:46AM	Exact Sciences price target raised to $70 from $60 at Evercore ISI (TipRanks)
06:00AM	Loading…
Jan-02-25 06:00AM	Exact Sciences to Participate in J.P. Morgan Healthcare Conference (Business Wire)
Nov-26-24 07:27PM	Analyst Report: Exact Sciences Corporation (Morningstar Research) +9.00%
01:24PM	Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED) (Benzinga)
06:00AM	Exact Sciences to Participate in December Investor Conferences (Business Wire)
Nov-25-24 05:35PM	Exact Sciences Advances Breast Cancer Care with the Oncotype DX test and Genomic Profiling Research at SABCS 2024 (Business Wire)
Nov-19-24 06:57PM	Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey) +8.84%
Nov-15-24 07:47AM	Exact Sciences showcases early cancer detection test data at AACR meeting (Clinical Trials Arena)
Nov-13-24 01:00PM	Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy (Business Wire)
Nov-11-24 09:55AM	Exact Sciences Corporation (EXAS) Rebounded from the Previous Quarter (Insider Monkey)
Nov-08-24 06:46AM	Exact Sciences forecast cut shocks analysts (MedTech Dive)
Nov-07-24 04:05PM	Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop (Investor's Business Daily)
10:05AM	Guardant Health Rockets 25% On An 'Impressive' Beat Following Exact Sciences' Flop (Investor's Business Daily)
Nov-06-24 04:04PM	Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken? (Investor's Business Daily) -23.48%
11:47AM	Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount (Investopedia)
10:22AM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
10:13AM	Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point (Benzinga)
06:55AM	Q3 2024 Exact Sciences Corp Earnings Call (Thomson Reuters StreetEvents)
02:24AM	Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
12:02AM	Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight (GuruFocus.com)
Nov-05-24 08:42PM	Exact Sciences Stock Falls 29% On Weak Results, Downbeat Outlook (Investor's Business Daily)
07:45PM	Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript (Motley Fool)
05:30PM	Exact Sciences (EXAS) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:29PM	Exact Sciences: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Exact Sciences Announces Third-Quarter 2024 Results (Business Wire)
Nov-01-24 06:00AM	Exact Sciences to Participate in November Investor Conference (Business Wire)
Oct-29-24 12:00PM	Exact Sciences (EXAS) Moves to Strong Buy: Rationale Behind the Upgrade (Zacks)
Oct-27-24 12:00PM	Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement (Business Wire)
Oct-17-24 08:00AM	Can This Beaten-Down Cathie Wood Stock Bounce Back? (Motley Fool)
Oct-16-24 10:34AM	Exact Sciences Corporation (EXAS) Bounced Back in Q3 (Insider Monkey)
Oct-09-24 03:36PM	Exact Sciences Corp (EXAS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Oct-08-24 06:00AM	Exact Sciences Schedules Third Quarter 2024 Earnings Call (Business Wire)
Oct-07-24 03:04PM	FMR LLC Bolsters Stake in Exact Sciences Corp (GuruFocus.com)
10:33AM	FDA greenlights Exact Sciences newest home colorectal cancer test (Medical Device Network)
06:49AM	Exact Sciences wins FDA approval for Cologuard Plus colorectal cancer test (MedTech Dive)
Oct-05-24 08:35AM	Exact Sciences Corporation (EXAS): A Buzzing AI Health Stock to Add to Your Portfolio (Insider Monkey)
Oct-04-24 09:41AM	FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test (Benzinga)
09:40AM	Exact Sciences Stock Rises After FDA Signs Off On New Cologuard (Investor's Business Daily)
06:00AM	FDA Approves Exact Sciences' Cologuard Plus Test, Setting a New Benchmark in Non-Invasive Colorectal Cancer Screening (Business Wire)
Sep-18-24 06:03PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
Sep-17-24 07:00AM	The Battle Brewing Over Blood Tests for Cancer (The Wall Street Journal)
Sep-16-24 07:55AM	Exact Sciences says data support its colon cancer blood test (MedTech Dive) +6.01%
07:53AM	ESMO 2024: Exact Sciences unveils results from cancer algorithm trial (Medical Device Network)
02:35AM	Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024 (Business Wire)
Sep-12-24 07:28PM	Analyst Report: Exact Sciences Corporation (Morningstar Research) +5.10%
Sep-11-24 07:18AM	Should You Hold Exact Sciences Corporation (EXAS)? (Insider Monkey) +9.83%
Sep-09-24 09:55AM	Wall Street Analysts Believe Exact Sciences (EXAS) Could Rally 34.33%: Here's is How to Trade (Zacks)
Aug-30-24 11:31AM	Exact Sciences (EXAS) Up 7.5% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-28-24 06:00AM	Exact Sciences to Participate in September Investor Conferences (Business Wire)
Aug-23-24 08:26AM	Should You Believe in the Growth Potential of Exact Sciences Corporation (EXAS)? (Insider Monkey)
06:00AM	Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG) (News Direct)
Aug-22-24 09:55AM	Does Exact Sciences (EXAS) Have the Potential to Rally 34.13% as Wall Street Analysts Expect? (Zacks)
09:23AM	Exact Sciences (EXAS) Rides on Cologuard Sales, New Launches (Zacks)
08:41AM	Exact Sciences (EXAS) Enrolls First Patient in Pivotal MCED Study (Zacks)
Aug-21-24 11:08PM	Atlassian Corporation (TEAM): Short Sellers Are Bullish On This Advertising Stock Now (Insider Monkey)
08:08AM	Heres Why Baron Opportunity Fund Sold its Stake in Exact Sciences Corp (EXAS) (Insider Monkey)
07:13AM	Exact Sciences kicks off multi-cancer detection study (Medical Device Network)
Aug-20-24 07:00AM	Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study (Business Wire)
Aug-16-24 07:13AM	Exact Sciences data finds Cologuard detected almost 600k cancer cases (Medical Device Network)
Aug-15-24 07:00AM	New Modeling Data Show the Cologuard Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion (Business Wire)
Aug-14-24 09:19AM	Why You Should Add Exact Sciences (EXAS) to Your Portfolio (Zacks)
Aug-11-24 02:47PM	Atlassian Corporation (TEAM): Hedge Funds Are Bullish on This AdTech Stock Now (Insider Monkey)
Aug-10-24 09:22PM	8 Best AdTech Stocks to Buy Now (Insider Monkey)
Aug-06-24 09:55AM	Wall Street Analysts Predict a 45.04% Upside in Exact Sciences (EXAS): Here's What You Should Know (Zacks)
Aug-02-24 01:08AM	Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight (GuruFocus.com)
Aug-01-24 04:02PM	Why Exact Sciences, Up 27%, Is 'Coiled To Snap Back' After Quarterly Beat (Investor's Business Daily) +26.77%
10:49AM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
09:03AM	Exact Sciences (EXAS) Q2 Loss Narrower Than Expected, Sales Beat (Zacks)
12:00AM	Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript (Motley Fool)
Jul-31-24 07:30PM	Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:28PM	Exact Sciences: Q2 Earnings Snapshot (Associated Press Finance)

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Conroy Kevin T	President and CEO	Mar 07 '25	Option Exercise	22.38	66,723	1,493,261	1,203,269	Mar 10 05:00 PM
Herriott James	SVP, General Counsel & Sec	Feb 28 '25	Option Exercise	0.00	4,265	0	16,339	Mar 04 04:48 PM
Conroy Kevin T	President and CEO	Feb 28 '25	Option Exercise	0.00	40,310	0	1,146,965	Mar 04 04:47 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 28 '25	Option Exercise	0.00	9,673	0	25,106	Mar 04 04:44 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 28 '25	Option Exercise	0.00	9,673	0	27,728	Mar 04 04:40 PM
Condella Sarah	EVP, Human Resources	Feb 28 '25	Option Exercise	0.00	7,738	0	84,399	Mar 04 04:37 PM
Condella Sarah	EVP, Human Resources	Feb 25 '25	Option Exercise	0.00	3,954	0	80,297	Feb 26 08:00 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 25 '25	Option Exercise	0.00	3,954	0	19,841	Feb 26 08:00 PM
Herriott James	SVP, General Counsel & Sec	Feb 25 '25	Option Exercise	0.00	1,647	0	13,738	Feb 26 08:00 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 25 '25	Option Exercise	0.00	3,954	0	22,136	Feb 26 08:00 PM
Conroy Kevin T	President and CEO	Feb 25 '25	Option Exercise	0.00	13,180	0	1,121,378	Feb 26 08:00 PM
Conroy Kevin T	President and CEO	Feb 19 '25	Option Exercise	0.00	10,374	0	1,084,565	Feb 21 04:30 PM
COWARD D SCOTT	Director	Feb 19 '25	Option Exercise	0.00	2,248	0	52,831	Feb 21 04:30 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 19 '25	Option Exercise	0.00	2,248	0	16,688	Feb 21 04:30 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 19 '25	Option Exercise	0.00	1,729	0	14,487	Feb 21 04:30 PM
Condella Sarah	EVP, Human Resources	Feb 19 '25	Option Exercise	0.00	2,248	0	74,859	Feb 21 04:30 PM
Herriott James	SVP, General Counsel & Sec	Feb 19 '25	Option Exercise	0.00	865	0	10,731	Feb 21 04:30 PM
Conroy Kevin T	President and CEO	Nov 13 '24	Buy	51.35	19,500	1,001,325	1,074,191	Nov 13 12:56 PM
Baranick Brian	EVP, GM, Precision Oncology	Oct 08 '24	Sale	70.00	929	65,030	12,758	Oct 09 05:00 PM
Baranick Brian	Officer	Oct 08 '24	Proposed Sale	70.00	929	65,030		Oct 08 01:27 PM
Baranick Brian	EVP, GM, Precision Oncology	Sep 18 '24	Sale	70.00	929	65,030	13,687	Sep 19 05:00 PM
Baranick Brian	Officer	Sep 18 '24	Proposed Sale	70.00	929	65,030		Sep 18 04:15 PM
Baranick Brian	EVP, GM, Precision Oncology	Aug 05 '24	Option Exercise	0.00	2,712	0	15,991	Aug 06 05:30 PM
COWARD D SCOTT	Director	May 01 '24	Sale	60.15	67	4,030	44,644	May 02 07:00 PM
Cunningham Everett	Chief Commercial Officer	May 01 '24	Sale	60.15	136	8,180	47,042	May 02 07:00 PM
Herriott James	SVP, General Counsel & Sec	May 01 '24	Sale	60.15	30	1,804	9,866	May 02 07:00 PM
Elliott Jeffrey Thomas	Chief Financial Officer	May 01 '24	Sale	60.15	136	8,180	11,795	May 02 07:00 PM
Baranick Brian	EVP, GM., Precision Oncology	May 01 '24	Sale	60.15	110	6,616	13,279	May 02 07:00 PM
Condella Sarah	EVP, Human Resources	May 01 '24	Sale	60.15	102	6,135	72,611	May 02 07:00 PM
ORVILLE JACOB A	General Manager, Screening	May 01 '24	Sale	60.15	102	6,135	14,440	May 02 07:00 PM
Conroy Kevin T	President and CEO	May 01 '24	Sale	60.15	1,155	69,473	1,156,191	May 02 07:00 PM
Condella Sarah	EVP, Human Resources	Apr 01 '24	Sale	70.00	2,000	140,000	71,787	Apr 03 07:30 PM
Baranick Brian	EVP, GM., Precision Oncology	Apr 02 '24	Sale	79.43	924	73,393	13,171	Apr 03 07:30 PM
Condella Sarah	EVP, Human Resources	Mar 28 '24	Sale	70.00	2,000	140,000	73,787	Apr 01 04:30 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EXAS

Exact Sciences Corp

Upgrade your FINVIZ experience